Biotech

All Articles

Analysts go into Avidity's DMD win, revealing subtleties in information

.Avidity Biosciences impressed financiers with phase 1/2 records in Duchenne muscle dystrophy (DMD) ...

Actinogen's cortisol blocker neglects stage 2 clinical depression research

.Actinogen Medical's cortisol blocker has overlooked the primary endpoint of a period 2 study in anx...

Bivictrix decides going private only means to take ADC into facility

.Antibody-drug conjugates (ADCs) have actually been at the facility of numerous a billion-dollar bio...

TPG leadings up funds to $580M for assets across life sciences

.Possession manager TPG, which has sustained biotechs including Sionna Rehabs and also Santa Clam An...

Merck quits stage 3 TIGIT test in bronchi cancer for futility

.Merck &amp Co.'s TIGIT system has suffered one more problem. Months after shuttering a stage 3 most...

After a challenging year, Exscientia folds up in to Recursion

.After a year described through pipeline hairstyles, the departure of its chief executive officer as...

Cullinan, after $25M package, hands back bispecific to Port

.Cullinan Rehab was actually impressed good enough along with Port BioMed's bispecific invulnerable ...

A better take a look at Fierce Biotech's Ferocious 15

.In this particular full week's incident of "The Leading Line," our company are actually diving in t...

Lilly experiences phase 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering commemorating the approval...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of significant leadership hirings, shootings and...